DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning

Information source: Sylhet M.A.G.Osmani Medical College
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Organophosphate Poisoning

Intervention: Standard care (Drug); Standard care+ 2.5 mg Salbutamol (Drug); Standard care+ 5 mg Salbutamol (Drug)

Phase: Phase 3

Status: Recruiting

Sponsored by: Sylhet M.A.G.Osmani Medical College

Official(s) and/or principal investigator(s):
Fazle R Chowdhury, FCPS, Principal Investigator, Affiliation: Consultant, Medicine, Sylhet M.A.G.Osmani Medical Collge, Sylhet, Bangladesh
Michael Eddleston, PhD, Principal Investigator, Affiliation: Professor of Clinical Toxicology, University of Edinburgh

Overall contact:
Fazle R Chowdhury, FCPS, Phone: +008801916578699, Email: mastershakil@hotmail.com

Summary

We hypothesize that salbutamol will speed removal of alveolar fluid compared to atropine alone in OP poisoned patients. We propose to compare the effect of two stat doses of nebulized salbutamol (2. 5 mg; 5. 0 mg), with nebulized saline placebo, in symptomatic patients receiving standard resuscitation with atropine, oxygen, and fluids after poisoning with OP pesticides. 25 patients will be randomised to each arm (total 75 patients). Primary outcome will be oxygen saturation's over the following 60 min during resuscitation. Secondary outcomes will include atropine dose administered, speed to stabilization, aspiration or pneumonia, intubation, tachydysrhythmias, and mortality. A positive outcome will result in design of a large definitive phase III study.

Clinical Details

Official title: Effect of Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen During Resuscitation of OP Pesticide Poisoned Patients

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Improvement of oxygen saturation

Secondary outcome: Heart rate, respiratory rate and Blood pressure

Detailed description: Pesticide self-poisoning kills over 300,000 people every year (1). Most deaths occur in rural Asia where widespread use of pesticides to boost food production allows easy access at stressful times. The WHO now recognizes pesticide poisoning to be the single most important global means of suicide (2) Amongst pesticides, organophosphorus (OP) and carbamate insecticides are of most concern, causing about 2/3 of deaths (1,3). These insecticides inhibit the enzyme acetylcholinesterase (AChE), producing an 'acute cholinergic crisis' with reduced consciousness, bradycardia, hypotension, and acute respiratory failure. On arrival at hospital, patients are resuscitated with atropine and, for OPs, an oxime AChE reactivator (4). Unfortunately, this treatment is often inadequate and many still die (5). A recent Bangladeshi RCT showed that rapid resuscitation of patients with atropine saves lives (6). This study compared a faster 'doubling dose' method of atropinisation with a standard bolus method during resuscitation. It reported quicker stabilisation and a 14% absolute reduction in mortality. Rationale: Atropine only stops production of fluid and does not speed its removal from the lung. Therefore a treatment that increases removal, to complement atropine-induced cessation of production, could reduce fluid in the lungs and speed return effective oxygen exchange. A single nebulised dose of the beta-adrenergic agonist salbutamol may increase removal since it increases alveolar fluid removal via the epithelial sodium channel. A pilot clinical study is required to test the hypothesis and to provide data for powering a large phase III RCT. Research question: Will addition of the beta-adrenergic agonist salbutamol to atropine during resuscitation improve oxygenation, reduce the need for atropine, and speed stabilisation? Objectives: General Objectives: To test the efficacy of salbutamol at increasing oxygenation and speeding resuscitation. Specific Objectives: To test whether salbutamol alters dose of atropine administered and incidence of tachydysrhythmias. Total duration of the study will be one year and all patients aged 12 years or older with clinical features of OP/carbamate poisoning requiring oxygen and atropine will be enrolled. The study will be done in three arms.

Eligibility

Minimum age: 12 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- age 12 yrs or older

- clinical features of OP poisoning

- requiring oxygen and atropine and give consent

Exclusion Criteria:

- age 11 yrs or younger

- no requirement for atropine

Locations and Contacts

Fazle R Chowdhury, FCPS, Phone: +008801916578699, Email: mastershakil@hotmail.com

Sylhet M.A.G.Osmani Medical College Hospital, Sylhet 3100, Bangladesh; Recruiting
Fazle R Chowdhury, FCPS, MSc., Phone: +008801916578699, Email: mastershakil@hotmail.com
Md. Shafiqul Bari, FCPS, Phone: +008801726948138, Email: drsbari_69@yahoo.com
Fazle R Chowdhury, FCPS, MSc., Principal Investigator
Additional Information

Related publications:

Abedin MJ, Sayeed AA, Basher A, Maude RJ, Hoque G, Faiz MA. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. J Med Toxicol. 2012 Jun;8(2):108-17. doi: 10.1007/s13181-012-0214-6.

Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet. 2008 Feb 16;371(9612):597-607. Review.

Gunnell D, Eddleston M, Phillips MR, Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health. 2007 Dec 21;7:357. Review.

Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. QJM. 2000 Nov;93(11):715-31. Review.

Starting date: April 2015
Last updated: May 25, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017